HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daniel Pauleikhoff Selected Research

chemotactic factor inactivator

11/2021Development of a Genotype Assay for Age-Related Macular Degeneration: The EYE-RISK Consortium.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Daniel Pauleikhoff Research Topics

Disease

34Macular Degeneration (Age-Related Maculopathy)
11/2023 - 10/2005
11Telangiectasis (Telangiectasia)
01/2022 - 04/2010
9Choroidal Neovascularization
10/2021 - 03/2004
6Atrophy
05/2022 - 03/2016
4Disease Progression
05/2016 - 12/2005
2Retinal Hemorrhage
11/2020 - 05/2011
1Fibrosis (Cirrhosis)
09/2023
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022
1Malnutrition (Nutritional Deficiencies)
12/2020
1Ischemia
11/2020
1Hemorrhage
11/2020
1Macular Edema
08/2019
1Retinal Diseases
08/2019
1Cicatrix (Scar)
05/2016
1Necrosis
01/2015
1Stargardt Disease
04/2012
1Papilledema
05/2011
1Uveitis
03/2007
1Polypoidal Choroidal Vasculopathy
11/2002

Drug/Important Bio-Agent (IBA)

13Retinaldehyde (Retinal)IBA
01/2023 - 12/2011
10Macular PigmentIBA
03/2016 - 04/2010
9Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2023 - 05/2011
7Retinal Pigments (Pigments, Visual)IBA
10/2021 - 03/2004
6Fluorescein (Funduscein)FDA LinkGeneric
10/2021 - 12/2005
4Ranibizumab (Lucentis)FDA Link
11/2020 - 05/2011
4LuteinIBA
07/2012 - 10/2005
4Complement Factor H (Factor H)IBA
04/2012 - 11/2007
3Biomarkers (Surrogate Marker)IBA
09/2023 - 01/2019
3Complement System Proteins (Complement)IBA
12/2020 - 01/2015
3ZeaxanthinsIBA
07/2012 - 10/2005
2Indocyanine Green (Cardio-Green)FDA LinkGeneric
10/2021 - 11/2002
2Complement C3 (C3 Complement)IBA
04/2012 - 10/2009
1Hypoglycemic Agents (Hypoglycemics)IBA
11/2023
1LipidsIBA
11/2023
1Serine (L-Serine)FDA Link
01/2022
1chemotactic factor inactivatorIBA
11/2021
1Lipoproteins (Lipoprotein)IBA
12/2020
1Essential Amino AcidsIBA
12/2020
1Endothelial Growth FactorsIBA
01/2019
1Ciliary Neurotrophic Factor (CNTF)IBA
01/2018
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
01/2015
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
01/2015
1ATP-Binding Cassette Transporters (ABC Transporters)IBA
04/2012
1LipofuscinIBA
03/2012
1Indicators and Reagents (Reagents)IBA
08/2011
1ocuvite plus luteinIBA
09/2010
11-phenyl-3,3-dimethyltriazene (PDT)IBA
09/2009
1EstersIBA
04/2007
1ZincIBA
04/2007
1Vitamin EFDA LinkGeneric
04/2007
1Ascorbic Acid (Vitamin C)FDA LinkGeneric
04/2007
1SeleniumIBA
04/2007
1Acetazolamide (Diamox)FDA LinkGeneric
03/2007
1Triamcinolone Acetonide (Azmacort)FDA LinkGeneric
03/2007
1Adrenal Cortex Hormones (Corticosteroids)IBA
03/2007
1C-Reactive ProteinIBA
11/2005
1Fibrinogen (Factor I)FDA Link
11/2005
1Carotenoids (Carotene)IBA
10/2005
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
03/2004

Therapy/Procedure

9Therapeutics
09/2023 - 05/2011
4Injections
10/2021 - 05/2011
3Intravitreal Injections
03/2021 - 03/2007
1Photochemotherapy (Photodynamic Therapy)
09/2009
1Vitrectomy
03/2007